Industry

Alport syndrome research is advancing rapidly, and partnerships with industry play a pivotal role in driving innovation.

By encouraging collaboration and using cutting-edge experimental systems, our research hub serves as a bridge between academic discovery and practical, impactful solutions for industry.

On this page:

• What the research hub can offer
• Industrial collaborations
• Contact

What the Alport research hub can offer 

The hub researchers are keen to engage with industry and support studies in Alport syndrome. This can be through a range of options: 

• Providing advice about preclinical studies and clinical trial design 
• Engaging in collaborative research through a sponsored research agreement 

< Back to top

Industrial collaborations 

To date our collaborations with industry have involved both the virtual and physical hubs. In the physical hub, sponsored research typically involves the experimental systems that we have developed for Alport syndrome research. 

Experimental systems used to investigate Alport syndrome:

• established models of Alport syndrome in kidney organoids (cell basement membranes) zebrafish (drug screening) and mouse models (Alport syndrome); 
• state-of-the-art in vivo and in vitro approaches with advanced imaging; 
• detailed analysis of basement membrane function; 
• a platform for the screening and testing of existing drugs, gene therapy effectiveness or potential new targets. 

These systems allow us to run tests in cells and in tissues, carry out detailed analysis of basement membrane function and test new drugs and gene therapies. 

< Back to top

Contact

If you would like advice about Alport syndrome research or would like to discuss a potential collaboration please contact us: 

Rachel Lennon (University of Manchester) 
Email: rachel.lennon@manchester.ac.uk  

Daniel Gale (University College London) 
Email: d.gale@ucl.ac.uk  

Neil Turner (University of Edinburgh) 
Email: neil.turner@ed.ac.uk  

< Back to top